FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to compounds of formula I, as well as to their physiologically acceptable salts 
wherein: X means NH; R1 means (C1-C6)-alkyl; R2 means OH; R2' means H; R5' means (C1-C6)-alkylene-O-S(O)2-R6; R3, R3', R4, R4' and R5 independently mean H, OH, (C1-C6)-alkylene-O-S(O)p-R6, O-(CH2)m-phenyl; at least one of the radicals R3, R3', R4, R4' and R5 has the value -O-(CH2)m-phenyl; R6 means OH; m=1; p=2.
EFFECT: compounds can find application in medicine, eg as lipid-lowering agents.
| Title | Year | Author | Number |
|---|---|---|---|
| CARBAMOYL BENZOTRIAZOLE DERIVATIVES AS LIPASE AND PHOSPHOLIPASE INHIBITORS | 2006 |
|
RU2430096C2 |
| COMBINED THERAPY INCLUDING SGLT INHIBITORS AND DPP4 INHIBITORS | 2009 |
|
RU2481106C2 |
| PHENYLOXALAMIDES, METHODS FOR PRODUCTION THEREOF AND USE THEREOF AS MEDICINAL AGENT | 2008 |
|
RU2488578C2 |
| NEW HETEROCYCLIC FLUORGLUCOSIDE DERIVATIVES, MEDICATIONS CONTAINING THESE COMPOUNDS, AND THEIR APPLICATION | 2003 |
|
RU2339641C2 |
| NOVEL FLUOROGLYCOSIDE DERIVATIVES OF PYRAZOLES, MEDICINE CONTAINING THEM, AND APPLICATION OF DERIVATIVES | 2005 |
|
RU2370499C2 |
| NOVEL AROMATIC FLUOROGLYCOSIDE DERIVATIVES, MEDICATIONS, CONTAINING SAID COMPOUNDS AND THEIR APPLICATION | 2003 |
|
RU2340622C2 |
| BI- AND POLYCYCLIC SUBSTITUTED ISOQUINOLINE AND ISOQUINOLINONE DERIVATIVES, USEFUL AS RHO-KINASE INHIBITORS | 2009 |
|
RU2532481C2 |
| METHOD OF PRODUCING COMPOUND USED AS TAFIa INHIBITOR | 2010 |
|
RU2538506C2 |
| METHOD OF OBTAINING 5- HALOGENALKYL-4,5-DIHYDROISOXAZOLE DERIVATIVES | 2008 |
|
RU2536039C2 |
| COMBINATIONS OF ACTIVATOR (ACTIVATORS) OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR), AND INHIBITOR (INHIBITORS) OF STEROL ABSORPTION AND TREATMENT OF VASCULAR DISEASES | 2008 |
|
RU2483724C2 |
